On May 6, 2025, the Company commenced a reduction in force ("RIF") that affected several employees, including the Former CFO and the Former CSO. In connection with the RIF, the Company entered into separation agreements with impacted employees providing termination benefits, including the continuation of base salary and monthly healthcare premiums, with benefit terms expiring at various dates through May 30, 2026.

On November 26, 2024, the Company's former chief executive officer (the "Former CEO") entered into a separation and consulting agreement pursuant to which the Former CEO is entitled to termination benefits until June 30, 2026, in the form of continuation of base salary and monthly healthcare premiums.

During the three months ended March 31, 2026, the Company entered into a separation agreement with an employee providing termination benefits, including the continuation of base salary and monthly healthcare premiums, with all payments to be completed by June 30, 2026. The Company recognized $0.1 million of expense associated with this separation agreement during the three months ended March 31, 2026, included in research and development expenses in the accompanying unaudited condensed statements of operations.

The following table provides a reconciliation of the beginning and ending liability balances for the three months ended March 31, 2026 (in thousands):


Balance, December 31, 2025	$	515
Termination benefit expense		85
Cash payments		(338	)
Balance, March 31, 2026	$	262